patients in clinical trial told Dr. Daniel S. Brandwein, D.P.M., F.A.C.F.A.S., that CBD eased pain and tension

Patients In Clinical Trial Told Dr. Daniel S. Brandwein, D.P.M., F.A.C.F.A.S, That CBD Eased Pain And Tension

Posted March 19, 2020

In NASDAQ: GWPH, NASDAQ: NBEV, NASDAQ: NEPT, NASDAQ: OGI, NYSE: CGC, NYSE: PG, OTC PINK: EDXC

Daniel S. Brandwein, D.P.M., F.A.C.F.A.S., a Florida board certified foot and ankle surgeon, podiatrist, calls CBD as part of his patients’ health and wellness protocol “cutting edge” in the relief from pain and tension. He has been named to the Board of CBD Unlimited, Inc., (OTC PINK: EDXC). He observed and administered a CBD one month trial as part of a clinical study in 2015 supported by CBD Unlimited, Inc., (OTC PINK: EDXC).

The global impact of the coronavirus has intensified coverage of companies that market CBD and other health-related products. Media firms such as stockmarketpress.com feature coverage of CBD and health-related stocks such as CBD Unlimited, Inc. (OTC PINK: EDXC), Johnson & Johnson (NASDAQ: JNJ), Procter & Gamble (NYSE: PG), Canopy Growth Corp. (NYSE: CGC), New Age Beverages Corp. (NASDAQ: NBEV), GW Pharmaceuticals PLC (NASDAQ: GWPH), Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT). Aurora Cannabis Inc. (NYSE:ACB) and OrganiGram Holdings Inc. (NASDAQ: OGI).

Patients In Clinical Trial Told Dr. Daniel S. Brandwein, D.P.M., F.A.C.F.A.S, That CBD Eased Pain And Tension

Dr. Daniel S. Brandwein, a podiatrist, recalled how his patients in a clinical study in 2015, supported by CBD Unlimited, Inc. (OTC PINK: EDXC), told him how the CBD administered to them performed. Dr. Brandwein said, “I observed and administered a CBD trial for one month through my practice. After the month-long trial, my patients were reporting relief from pain and tension. From here, I knew that I needed to be part of something special and cutting-edge in order to provide the very best care to my patients and to patients around the world.”

Today (March 19, 2020), CBD Unlimited, Inc., (OTC PINK: EDXC) named to its Board CBD health proponent and Florida board-certified foot and ankle surgeon Dr. Daniel S. Brandwein, D.P.M., F.A.C.F.A.S. The podiatrist is a proponent of CBD for overall health and wellness protocol who observed and executed a CBD clinical trial supported by CBD Unlimited, Inc., (OTC PINK: EDXC). Patients in clinical trial told Dr. Daniel S. Brandwein, D.P.M., F.A.C.F.A.S, that CBD eased pain and tension.

Todd Davis, chairman and CEO of CBD Unlimited, Inc., (OTC PINK: EDXC), said, “Dr. Brandwein witnessed exceptional outcomes in early stage clinical studies sponsored by CBD Unlimited and now his patients as well as countless other patients rely on CBD Unlimited’s products as part of their day-to-day health regimen. We are thrilled to welcome such a distinguished and accomplished individual to our Advisory Board. Dr. Brandwein’s clinical experience will prove to be a significant advantage in the long-term objectives of the company.” CBD Unlimited, Inc., (OTC PINK: EDXC) names to its Board CBD health proponent and surgeon Dr. Daniel S. Brandwein, D.P.M., F.A.C.F.A.S.

Patients Told Dr. Brandwein That CBD Eased Pain And Tension

Dr. Brandwein, in addition to his expertise in pain management and therapeutic treatments, has authored several scientific papers, the company said. Dr. Brandwein commented, “I am honored to serve as a board member for CBD Unlimited and will continue to promote the advancement of CBD use as part of patients’ overall health and wellness protocol.” Patients in clinical trial told Dr. Daniel S. Brandwein, D.P.M., F.A.C.F.A.S, that CBD eased pain and tension.

CBD Unlimited, Inc. (OTC PINK: EDXC) Is a Provider Of Innovative Phytonutrient-Based Food And Nutritional Products

CBD Unlimited, Inc. (OTC PINK: EDXC) markets all-natural CBD products in the form of oils, capsules, topicals and pet soft chew CBD products. The common goal of the line is therapeutic and pain relief for humans and pets, reducing pain, inflammation and separation anxiety.

CBD Unlimited, Inc. (OTC PINK: EDXC) ensures its CBD products are highest quality, American-manufactured and tightly controlled by a corporate seed-to-shelf manufacturing strategy. Its hemp is certified and grown in Colorado and Kentucky. It has premium genetics and superior quality, the company said in its recent Corporate Presentation. Its extracts in processing are rich in phyto-cannabinoids and terpenoids which are non-psychoactive. Product is cGMP Certified (Good Manufacturing Practice Certification).

CBD Unlimited, Inc. (OTC PINK: EDXC) And The CBD Demand As A Calming Agent

CBD is not a cure for coronavirus although its properties address key elements. It is known to offer anti-viral, anti-inflammatory and anti-bacterial properties. It also acts as an effective treatment for nausea and vomiting, which can be induced by the coronavirus in humans.

Source: Stock Market Press

Join Stock Market Press’ newsletter for the latest in IPO, market commentary and company profiles.

Stock Market Press is a financial news company that delivers up to date stock news, introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network.

Contact:

Stock Market Press
110 Wall St.
New York, NY 10005 info@stockmarketpress.com Safe Harbor Statement:

Statements in this news release may be ”forward-looking statements.” Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Stock Market Press undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.

See Stock Market Press disclaimer: https://stockmarketpress.com/disclaimer/ SOURCE: Stock Market Press

Nitin Harlalka

Nitin Harlalka is a Stock Market Press contributor who has covered financial market for close a decade. With a graduate degree in Economics, Nitin has been a freelance stock market and business journalist for a range of publications. Most recently, he has covered emerging industries such as cannabis and blockchain.